BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors.EBI
University of Oxford
Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.EBI
University of Oxford
Lysine demethylases inhibitors.EBI
Kyoto Prefectural University of Medicine
Inhibitors of histone demethylases.EBI
University of Copenhagen
Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.EBI
Sejong University
Design, synthesis and evaluation of the novel chalcone derivatives with 2,2-dimethylbenzopyran as HIF-1 inhibitors that possess anti-angiogenic potential.EBI
Shenyang Pharmaceutical University
Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets.EBI
University College London
Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) Inhibitors.EBI
University of Oxford
Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy.EBI
China Pharmaceutical University
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.EBI
University of Oxford
Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications.EBI
China Pharmaceutical University
Inhibition of a viral prolyl hydroxylase.EBI
University of Oxford
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.EBI
Sapienza University of Rome
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitorsBDB
Merck Sharp & Dohme